Logo
x

Search

Subscribe Now

All Posts by Date

Sun Pharmaceuticals' Absorica Received the US FDA's Approval for Severe Recalcitrant Nodular Acne

Sun Pharmaceuticals' Absorica Received the US FDA's Approval for Severe Recalcitrant Nodular Acne

  • November 5, 2019
Boehringer Ingelheim and Lilly Restructure their Alliance to Emphasis Full Expertise and Investment on Jardiance

Boehringer Ingelheim and Lilly Restructure their Alliance to Emphasis Full Expertise and Investment on Jardiance

  • November 5, 2019
Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

  • November 5, 2019
Takeda to Divest its Portfolio of Select OTC and Non-Core Assets to STADA for ~$660M

Takeda to Divest its Portfolio of Select OTC and Non-Core Assets to STADA for ~$660M

  • November 5, 2019
Sanofi's Fluzone High-Dose Quadrivalent (Influenza Vaccine) Receives the FDA's Approval for Adults Aged≥ 65yrs.

Sanofi's Fluzone High-Dose Quadrivalent (Influenza Vaccine) Receives the FDA's Approval for Adults Aged≥ 65yrs.

  • November 5, 2019
Henlius and Ascentage Pharma Collaborate to Evaluate the Combination Therapy for Chronic Lymphocytic Leukemia in China

Henlius and Ascentage Pharma Collaborate to Evaluate the Combination Therapy for Chronic Lymphocytic Leukemia in China

  • November 5, 2019
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.